Clinically relevant motor behaviors in Parkinson’s disease (PD) Models
Supported by:
7 July 2015
ABOUT THIS WEBINAR
Parkinson’s disease (PD) is characterized by well-defined motor symptoms, the most striking of which is bradykinesia. Bradykinesia, is typically caused by a reduction in dopaminergic transmission and is reliably reversed by clinically proven drugs. However, given the limited success of dopamine replacement therapies in PD patients, non-dopaminergic therapeutics to treat PD symptoms and underlying disease are being developed. These new approaches require more sophisticated tools to investigate therapy impact in rodent models.
The rest of this content is restricted - login or subscribe free to access
Thank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login.
Why subscribe? Join our growing community of thousands of industry professionals and gain access to:
- quarterly issues in print and/or digital format
- case studies, whitepapers, webinars and industry-leading content
- breaking news and features
- our extensive online archive of thousands of articles and years of past issues
- ...And it's all free!
Click here to Subscribe today Login here
Related conditions
Parkinson's disease
Related organisations
Charles River Laboratories
